You have 9 free searches left this month | for more free features.

Sirturo

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +3 more
Jun 22, 2023

Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • Dasmariñas, Philippines
  • +1 more
Jun 21, 2022

Tuberculosis, HIV Trial in Lima, Cape Town (Bedaquiline, Delamanid, Dolutegravir)

Completed
  • Tuberculosis
  • HIV Infections
  • Lima, Peru
  • +2 more
Jan 20, 2022

Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

Active, not recruiting
  • Tuberculosis
  • +4 more
  • Bedaquiline Oral Tablet
  • +7 more
  • Port Elizabeth, Eastern Cape, South Africa
  • +1 more
Oct 20, 2022

Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis Trial in Worldwide (TBAJ-876, Pretomanid, Linezolid)

Not yet recruiting
  • Pulmonary TB
  • +2 more
  • Tbilisi, Georgia
  • +20 more
Sep 22, 2023

MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

Active, not recruiting
  • MDR-TB
  • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
  • +9 more
  • Addis Ababa, Ethiopia
  • +12 more
Oct 12, 2022

Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Tbilisi, Georgia
  • +11 more
Feb 14, 2022

Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Tuberculosis Infection
  • Denver, Colorado
  • +14 more
Mar 2, 2023

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

Active, not recruiting
  • Tuberculosis, Pulmonary
  • +5 more
  • Tbilisi, Georgia
  • +10 more
Jan 26, 2022

Multidrug Resistant Tuberculosis Trial in Belarus, South Africa, Uzbekistan (Bedaquiline, Pretomanid, Moxifloxacin)

Recruiting
  • Multidrug Resistant Tuberculosis
  • Minsk, Belarus
  • +5 more
May 12, 2021

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South

Active, not recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +4 more
May 12, 2021

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculoses Trial in Belarus, South

Recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +6 more
May 12, 2021

Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Minsk, Belarus
  • +6 more
May 12, 2021

Healthy Trial in Antwerpen (Bedaquiline (Test formulation), Bedaquiline (Reference formulation))

Completed
  • Healthy
  • Bedaquiline (Test formulation)
  • Bedaquiline (Reference formulation)
  • Antwerpen, Belgium
    SGS Life Science Services
Jan 21, 2020

Tuberculosis Trial in South Africa, Tanzania, Uganda (PA-824, bedaquiline, moxifloxacin)

Completed
  • Tuberculosis
  • Tembisa, Gauteng, South Africa
  • +9 more
May 28, 2019

Pharmacometrics to Advance Novel Regimens for Drug-resistant

Recruiting
  • Multi-drug Resistant Tuberculosis
    • Almaty, Kazakhstan
    • +6 more
    Nov 1, 2022

    Patients Exposed to Bedaquiline

    Completed
    • Pulmonary Multi-drug Resistant Tuberculosis
    • No Intervention
    • Raleigh, North Carolina
      (unnamed)
    Jun 25, 2019

    Tuberculosis Trial in Bellville (bedaquiline)

    Completed
    • Tuberculosis
    • Bellville, Western Cape, South Africa
      TASK Clinical Research Centre
    Jul 26, 2017

    Pulmonary Tuberculosis Trial in Belville (TMC207, Rifafour e-275 mg)

    Completed
    • Pulmonary Tuberculosis
    • Belville, Cape Town, South Africa
      Karl Bremer Hospital
    Mar 15, 2017